The Effect of Use of Breathing Exercise Device and Reading Aloud on Vital Signs

Sponsor
Inonu University (Other)
Overall Status
Completed
CT.gov ID
NCT04978831
Collaborator
(none)
131
1
3
15
8.7

Study Details

Study Description

Brief Summary

Purpose of the research; To determine the effects of wearable technology follow-up, breathing exercises with a breathing exercise device and reading aloud on vital signs, fatigue and respiratory function parameters in individuals with COPD. This research will be conducted using a randomized controlled trial model. "Personal Description Form", "COPD and Asthma Fatigue Scale", Visual Analog Scale and pulmonary function tests will be used in data collection.

Condition or Disease Intervention/Treatment Phase
  • Device: PEP Device
  • Other: Reading Aloud
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
131 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Use of Breathing Exercise Device and Reading Aloud on Vital Signs, Fatigue and Pulmonary Function Parameters in Patients With COPD Who Followed Up by Wearable Technology
Actual Study Start Date :
Nov 1, 2020
Actual Primary Completion Date :
Jan 3, 2022
Actual Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Respiratory exercise device group

Device: PEP Device
The breathing exercise device is a device that simulates pursed-lip breathing by creating positive expiratory pressure (PEP). Before starting to use the device, it will be explained that they need to put the mouthpiece on the device and put the nose clip on their nose, and the participants will be shown how it is done. The device will be used at 5 cmH2O pressure. A single exercise session consists of 3 exercise cycles, and a single exercise cycle consists of 15 breathing-exhalation activities. Participants will complete 3 cycles (a total of 45 inhales and exhales) in a single session. 1 loop lying on the left side, 1 loop lying on the right side, and 1 loop in sitting upright position. Participants held these sessions in the morning, afternoon, and evening. After completing each cycle, the participants will remove their nose clips and cough 2-3 times. Each participant will perform a total of 135 breathing exercises in one day.
Other Names:
  • Smart Watch
  • Experimental: Reading aloud group

    Other: Reading Aloud
    The patients in this group were given a book that they chose from among the book types within the scope of the study, according to their wishes. For the selection of books, opinions were taken from the experts in the education faculty of the same university and it was stated that any book separation was not important. The books that the participants wanted to read were provided by the researcher. They were asked to read this book aloud during the day, sitting upright on a chair or sofa, for 15 minutes, three times a day. They were able to stop reading when the participant was tired or felt too short of breath to continue reading.

    No Intervention: Control group

    Outcome Measures

    Primary Outcome Measures

    1. Pulmonary Function Parameters [2 month]

      Change in FEV1/FVC ratio will be evaluated with pulmonary function test

    2. Fatigue [2 month]

      The COPD and Asthma Fatigue Scale was developed by Revicki et al in 2010 to reveal the effect of COPD and Asthma on fatigue. The items of the questions in the scale, which consists of 12 questions in total, are graded with a 5-point Likert type as "never", "rarely", "sometimes", "often", "very often". A total of 12 to 60 points is obtained from the scale. A single score is obtained from the scale for the state of fatigue, and there is no evaluation of the sub-dimensions. An increase in this score indicates that the person's fatigue level is high.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Having been diagnosed with COPD for at least 6 months or before

    • Not having a respiratory system defect caused by diseases other than COPD

    • Not in the GOLD-4 COPD stage

    • Being able to read and write Turkish

    • Have no problems communicating or speaking

    • Being able to use basic information technologies

    • Using a smartphone

    • Having an active internet connection

    Exclusion Criteria:
    • Having non-COPD pulmonary problems and diagnosed cardiovascular disease

    • Not volunteering to participate in the study

    • Having a psychiatric disorder such as schizophrenia or dementia that disrupts the thought process

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 İnönü University Malatya Turkey

    Sponsors and Collaborators

    • Inonu University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Gürkan ÖZDEN, Research Assistant, Inonu University
    ClinicalTrials.gov Identifier:
    NCT04978831
    Other Study ID Numbers:
    • 10368355
    First Posted:
    Jul 27, 2021
    Last Update Posted:
    Mar 31, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Gürkan ÖZDEN, Research Assistant, Inonu University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 31, 2022